↓ Skip to main content

Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects

Overview of attention for article published in Frontiers in immunology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
11 X users
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
210 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
Published in
Frontiers in immunology, March 2022
DOI 10.3389/fimmu.2022.835762
Pubmed ID
Authors

Paul Shafer, Lauren M. Kelly, Valentina Hoyos

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 210 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 27 13%
Researcher 20 10%
Unspecified 11 5%
Student > Master 9 4%
Student > Bachelor 9 4%
Other 20 10%
Unknown 114 54%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 28 13%
Immunology and Microbiology 21 10%
Unspecified 11 5%
Medicine and Dentistry 11 5%
Agricultural and Biological Sciences 9 4%
Other 13 6%
Unknown 117 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2024.
All research outputs
#2,703,981
of 25,744,802 outputs
Outputs from Frontiers in immunology
#2,777
of 32,300 outputs
Outputs of similar age
#63,087
of 451,435 outputs
Outputs of similar age from Frontiers in immunology
#133
of 1,662 outputs
Altmetric has tracked 25,744,802 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,300 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,435 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 1,662 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.